We determined the serum concentrations of HBD2, HMGB-1, Claudin-3 and Relmβ by enzyme-linked immunosorbent assay (ELISA) and combined them with other clinical indicators to explore their predictive value in NEC surgery decision-making. This evidence concerns the gene CLDN3 and necrotizing enterocolitis.